MedPath

Evaluation of Effect of glycerin suppository in prevention of neonatal jaundice in besat hospital in sanandaj in 2016-17

Phase 1
Conditions
neonatal jundice.
Neonatal jaundice from other and unspecified causes
Registration Number
IRCT20180306038980N1
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
220
Inclusion Criteria

all of the newborn of besat hospital of sanandaj and referred newborn to that hospital

Exclusion Criteria

under 2500 gr weight
birth before 37th week of pregnancy
positive combs
ABO
FEVER
Fever
GDM
Cephalohematoma
addicted mother
c/s

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Billirubin range. Timepoint: 12,24 and 48 hours and 5 day after birth. Method of measurement: bilicheck instrument.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath